Atlas Trials

Evaluation of the Safety, Tolerability and Efficacy of a Gene Therapy Drug for the Treatment of Pediatric Fabry Disease

Clinical trial NCT06207552 · RECRUITING

Trial details

NCT number
NCT06207552
Sponsor
Children's Hospital of Fudan University
Status
RECRUITING
Phase
Early Phase 1
Study type
INTERVENTIONAL
Fabry Disease
Start date
2024-02-20
Primary completion
2025-06-01
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.